Trial Profile
Clinical Trials Insight: 700029329
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs SB 773812 (Primary) ; Antipsychotics
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 18 Dec 2007 New trial record.